|
|
Volumn 15, Issue 1, 2000, Pages 71-81
|
|
Cost-effective therapy for acute exacerbations of chronic bronchitis
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMOXICILLIN;
AMOXICILLIN PLUS CLAVULANIC ACID;
AMPICILLIN;
ANTIBIOTIC AGENT;
BETA LACTAMASE INHIBITOR;
CEPHALOSPORIN DERIVATIVE;
CHLORAMPHENICOL;
CIPROFLOXACIN;
COTRIMOXAZOLE;
DOXYCYCLINE;
MACROLIDE;
OXYTETRACYCLINE;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
ANTIBIOTIC THERAPY;
CHRONIC BRONCHITIS;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
CLINICAL TRIAL;
COST BENEFIT ANALYSIS;
COST EFFECTIVENESS ANALYSIS;
DISEASE EXACERBATION;
HEALTH CARE COST;
HIGH RISK PATIENT;
HOSPITALIZATION;
HUMAN;
PRIORITY JOURNAL;
RESPIRATORY FAILURE;
REVIEW;
TREATMENT FAILURE;
|
|
EID: 0034063120
PISSN: 08820546
EISSN: None
Source Type: Journal
DOI: 10.1053/srin.2000.0150071 Document Type: Review |
|
Times cited : (26)
|
|
References (60)
|
